GVHD: A Continuing Barrier to the Safety of Allogeneic Transplantation (original) (raw)

2009, Biology of Blood and Marrow Transplantation

AI-generated Abstract

Acute and chronic graft-versus-host disease (GVHD) are significant complications that hinder the efficacy of allogeneic hematopoietic cell transplantation, leading to increased morbidity and mortality. This article reviews the underlying mechanisms of GVHD, emphasizing the importance of preclinical models in understanding pathophysiology, particularly in the activation of antigen presenting cells (APCs), and the subsequent immune responses. It highlights innovative assessment strategies and potential therapeutic approaches to enhance treatment outcomes for chronic GVHD, while discussing the immunosuppressive effects of GVHD on post-transplant immune defenses.

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact